DKSH has divested OLIC, a contract manufacturer of pharmaceutical products in Thailand, to Fuji Pharma Co. Ltd. DKSH plans to focus on its market expansion services in Asia. The transaction is subject to customary closing conditions.   Dr. Joerg Wolle, president and chief executive officer of DKSH Group, said, “This decision is in line with our strategy for sustainable profitable growth, where our focus is on our core competency as a provider of Market Expansion Services, from sourcing, marketin...